Anti-PD-1 Immunotherapy Melanoma (Anti-PD-1_MELANOMA) - The Cancer Imaging Archive (TCIA) Public Access -....

Summary Redirection Notice This page will redirect to https://www.cancerimagingarchive.net/collection/anti-pd-1_melanoma/ in about 5 seconds. This collection includes 47 melanoma cases...

ANTI-PD-1_MELANOMA - The Cancer Imaging Archive (TCIA)

DOI: 10.7937/tcia.2019.1ae0qtcu | Data Citation Required| Location : Skin, Species : Human, Subjects : 47, Data Types : CT, MR, PT, Cancer Types : Melanoma, Size : 98.41GB, Status : Limited, Complete, Updated : 2018/07/30

[논문]PD‐L1 expression in melanoma shows marked heterogeneity within and between patients: implications ....

SummaryThis study evaluated the expression of PD‐L1 in immunotherapy‐naïve metastatic melanoma patients to determine longitudinal intrapatient concordance and correlate PD‐L1 status with clinicopat...

Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth

Therapeutic antibodies targeting programmed cell death 1 (PD-1) activate tumor-specific immunity and have shown remarkable efficacy in the treatment of melanoma. Yet, little is known about tumor ce...

A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma

Immunologic responses to anti-PD-1 therapy in melanoma patients occur rapidly with pharmacodynamic T cell responses detectable in blood by 3 weeks. It is unclear, however, whether these early blood...

[논문]Anti‐PD‐1 antibodies in metastatic uveal melanoma: a treatment option? - 과학기술 지식인프라 Scie....

*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.

MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma

Combination anti-cytotoxic T lymphocyte antigen 4 (CTLA-4) and anti-programmed cell death protein 1 (PD-1) therapy promotes antitumor immunity and provides superior benefit to patients with advance...

[논문]The efficacy of anti‐PD‐1 agents in acral and mucosal melanoma - 과학기술 지식인프라 ScienceON (사....

BACKGROUNDTherapeutic antibodies against programmed cell death receptor 1 (PD‐1) are considered front‐line therapy in metastatic melanoma. The efficacy of PD‐1 blockade for patients with biological...

m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade

Knockdown of FTO sensitizes melanoma cells to interferon gamma (IFNγ) and sensitizes melanoma to anti-PD-1 treatment in mice, depending on adaptive immunity. Our findings demonstrate a...

Analytica | Free Full-Text | Quantification of PD-1/PD-L1 Interaction between Membranes from PBMCs and Me....

Melanoma is a carcinoma known to evade the host immune defenses via the downregulation of the immune response. One of the molecules involved in this mechanism is programmed cell death ligand 1 (PD-...